Haraf D - Search Results

1

Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer.

Brachman DG, Graves D, Vokes E, Beckett M, Haraf D, Montag A, Dunphy E, Mick R, Yandell D, Weichselbaum RR. Brachman DG, et al. Among authors: haraf d. Cancer Res. 1992 Sep 1;52(17):4832-6. Cancer Res. 1992. PMID: 1324797

2

Cellular and molecular mechanisms of radioresistance.

Weichselbaum RR, Beckett MA, Vokes EE, Brachman DG, Haraf D, Hallahan D, Kufe D. Weichselbaum RR, et al. Among authors: haraf d. Cancer Treat Res. 1995;74:131-40. doi: 10.1007/978-1-4615-2023-8_7. Cancer Treat Res. 1995. PMID: 7779612 Review. No abstract available.

3

p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines.

Brachman DG, Beckett M, Graves D, Haraf D, Vokes E, Weichselbaum RR. Brachman DG, et al. Among authors: haraf d. Cancer Res. 1993 Aug 15;53(16):3667-9. Cancer Res. 1993. PMID: 8339273

4

An exploration of the pretreatment coping strategies of patients with carcinoma of the head and neck.

List MA, Lee Rutherford J, Stracks J, Haraf D, Kies MS, Vokes EE. List MA, et al. Among authors: haraf d. Cancer. 2002 Jul 1;95(1):98-104. doi: 10.1002/cncr.10653. Cancer. 2002. PMID: 12115322 Free article.

5

Hydroxyurea with continuous infusion paclitaxel, 5-fluorouracil, and concomitant radiotherapy for poor-prognosis head and neck cancer.

Vokes EE, Stupp R, Haraf D, Moran W, Malone D, Wenig B, Sweeney P, Weichselbaum RR. Vokes EE, et al. Among authors: haraf d. Semin Oncol. 1995 Jun;22(3 Suppl 6):47-52. Semin Oncol. 1995. PMID: 7597433 Review.

6

The Performance Status Scale for Head and Neck Cancer Patients and the Functional Assessment of Cancer Therapy-Head and Neck Scale. A study of utility and validity.

List MA, D'Antonio LL, Cella DF, Siston A, Mumby P, Haraf D, Vokes E. List MA, et al. Among authors: haraf d, d antonio ll. Cancer. 1996 Jun 1;77(11):2294-301. doi: 10.1002/(SICI)1097-0142(19960601)77:11<2294::AID-CNCR17>3.0.CO;2-S. Cancer. 1996. PMID: 8635098

7

Cisplatin, fluorouracil, and leucovorin augmented by interferon alfa-2b in head and neck cancer: a clinical and pharmacologic analysis.

Vokes EE, Ratain MJ, Mick R, McEvilly JM, Haraf D, Kozloff M, Hamasaki V, Weichselbaum RR, Panje WR, Wenig B, et al. Vokes EE, et al. Among authors: haraf d. J Clin Oncol. 1993 Feb;11(2):360-8. doi: 10.1200/JCO.1993.11.2.360. J Clin Oncol. 1993. PMID: 8426214 Clinical Trial.

8

Performance and quality of life outcome in patients completing concomitant chemoradiotherapy protocols for head and neck cancer.

List MA, Mumby P, Haraf D, Siston A, Mick R, MacCracken E, Vokes E. List MA, et al. Among authors: haraf d. Qual Life Res. 1997 Apr;6(3):274-84. doi: 10.1023/a:1026419023481. Qual Life Res. 1997. PMID: 9226985

9

Temporal bone chemodectomas--comparing surgery and radiation therapy.

Springate SC, Haraf D, Weichselbaum RR. Springate SC, et al. Among authors: haraf d. Oncology (Williston Park). 1991 Apr;5(4):131-7; discussion 140, 143. Oncology (Williston Park). 1991. PMID: 1651096 Review.

10

In vitro radiobiological parameters of human sarcoma cell lines.

Weichselbaum RR, Beckett MA, Simon MA, McCauley C, Haraf D, Awan A, Samuels B, Nachman J, Dritschilo A. Weichselbaum RR, et al. Among authors: haraf d. Int J Radiat Oncol Biol Phys. 1988 Oct;15(4):937-42. doi: 10.1016/0360-3016(88)90129-0. Int J Radiat Oncol Biol Phys. 1988. PMID: 3182333

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

171 results

Search Page

Filters